INTRATUMORAL ALPHA-EMITTER RADIATION IN COMBINATION WITH VASCULATURE INHIBITORS

A vascular inhibitor for use as a medicament for treatment of a tumor of a patient wherein the administration pattern of the medicament comprises administering a therapeutically effective amount of the vascular inhibitor to the patient, in one or more sessions, and implanting seeds (204) carrying ra...

Full description

Saved in:
Bibliographic Details
Main Authors DEN, ROBERT, SHAI, AMIT, VATARESCU, MAAYAN HEDVA, KEISARI, YONA, NISHRI, YOSSI, SEGAL, RONEN, LUZ, ISHAI, DEL MARE ROUMANI, SARA, EFRATI, MARGALIT, DOMANKEVICH, VERED, KELSON, ITZHAK, COOKS, TOMER
Format Patent
LanguageEnglish
French
Published 29.12.2022
Subjects
ELECTROTHERAPY
HUMAN NECESSITIES
HYGIENE
MAGNETOTHERAPY
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
RADIATION THERAPY
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
ULTRASOUND THERAPY
Online AccessGet full text

Cover

More Information
Summary:A vascular inhibitor for use as a medicament for treatment of a tumor of a patient wherein the administration pattern of the medicament comprises administering a therapeutically effective amount of the vascular inhibitor to the patient, in one or more sessions, and implanting seeds (204) carrying radium-224 in the tumor for intra-tumoral alpha-emitter radiotherapy less than two weeks from administering the vascular inhibitor. L'invention concerne un inhibiteur vasculaire destiné à être utilisé en tant que médicament pour le traitement d'une tumeur d'un patient, le schéma d'administration du médicament comprenant l'administration d'une dose thérapeutiquement efficace de l'inhibiteur vasculaire au patient, lors d'une ou de plusieurs séances, ainsi que l'implantation de grains (204) véhiculant du radium-224 dans la tumeur en vue d'une radiothérapie par émetteur alpha intratumoral moins de deux semaines après l'administration de l'inhibiteur vasculaire.
Bibliography:Application Number: CA20223224888